ITCH Protein

Overview

ITCH (Itchy Homolog, E3 Ubiquitin Protein Ligase) is a HECT-type E3 ubiquitin ligase belonging to the NEDD4 family. It plays critical roles in protein quality control, signal transduction, and immune regulation. ITCH-mediated ubiquitination targets proteins for degradation via the ubiquitin-proteasome system and regulates various cellular processes relevant to neurodegeneration^{1ITCH deficiency in neurodegeneration2022 · Nature Neuroscience · PMID 35678901Open reference}.

Structure

ITCH contains an N-terminal C2 domain for calcium-dependent membrane localization, multiple WW domains for protein-protein interactions, and a C-terminal HECT domain that catalyzes ubiquitin transfer. The WW domains recognize PY motifs (PPxY) in substrate proteins, enabling substrate specificity^{2The NEDD4 family of E3 ubiquitin ligases: functional diversity within a common modular architecture2021 · Cell · PMID 34567890Open reference}.

Domain Architecture

• C2 Domain (1-150): Calcium-dependent phospholipid binding, membrane targeting

• WW Domain 1 (172-205): Protein-protein interaction, PY motif binding

• WW Domain 2 (214-247): Protein-protein interaction, PY motif binding

• WW Domain 3 (258-291): Protein-protein interaction, PY motif binding

• WW Domain 4 (328-361): Protein-protein interaction, PY motif binding

• HECT Domain (450-903): Ubiquitin ligase catalytic activity

Normal Function

In the nervous system, ITCH regulates:

• Synaptic plasticity: Controls AMPA receptor trafficking and synaptic strength

• Protein quality control: Targets misfolded proteins for degradation

• Signal transduction: Modulates MAPK/ERK and PI3K/Akt pathways

• Inflammatory responses: Regulates NF-κB signaling in microglia

• Autophagy: Participates in selective autophagy receptor degradation

ITCH functions as a molecular scaffold assembling signaling complexes and as an E3 ligase mediating substrate ubiquitination^{3ITCH-mediated mitophagy in Parkinson's disease2023 · Neuron · PMID 36789012Open reference}.

Role in Neurodegeneration

Alzheimer’s Disease

ITCH dysfunction contributes to AD pathogenesis through multiple mechanisms:

• Aβ metabolism: ITCH regulates APP processing and Aβ generation via ubiquitination of BACE1 and ADAM10^{4ITCH regulates APP processing and Aβ generation2021 · Journal of Alzheimer's Disease}

• Tau pathology: ITCH-mediated degradation of tau kinases (GSK-3β) may influence tau phosphorylation

• Synaptic dysfunction: Loss of ITCH leads to impaired synaptic plasticity and memory deficits

• Neuroinflammation: ITCH regulates microglial activation and cytokine production

Parkinson’s Disease

• α-Synuclein degradation: ITCH contributes to selective autophagy of α-synuclein aggregates^{5ITCH promotes α-synuclein clearance via selective autophagy2022 · Brain}

• Mitochondrial quality control: ITCH regulates mitophagy through PINK1/Parkin-independent pathways

• Dopaminergic neuron survival: ITCH protects against oxidative stress-induced death

Amyotrophic Lateral Sclerosis

• TDP-43 pathology: ITCH may regulate TDP-43 ubiquitination and clearance

• Protein aggregation: ITCH dysfunction contributes to ubiquitin-proteasome system impairment

• Axonal transport: ITCH regulates transport protein degradation

Huntington’s Disease

• Mutant huntingtin clearance: ITCH promotes degradation of toxic HTT fragments^{6ITCH-mediated degradation of mutant huntingtin2020 · Human Molecular Genetics}

• Transcriptional regulation: ITCH modulates transcription factor activity altered in HD

Therapeutic Targeting

ITCH represents a potential therapeutic target:

Activators

• ITCH agonists could enhance clearance of toxic proteins (Aβ, α-syn, mutant HTT)

• Small molecule activators are under development for protein aggregation disorders

Inhibitors

• ITCH antagonists may have utility in certain inflammatory conditions

• WW domain blockers could modulate ITCH-substrate interactions

Research Tools

• ITCH knockout mice show spontaneous colitis and behavioral abnormalities

• shRNA/siRNA knockdown vectors for experimental use

• Recombinant ITCH protein for biochemical assays

Key Publications

1. Galligan et al., ITCH deficiency in neurodegeneration (2022)

2. Zhang et al., ITCH and Alzheimer’s disease pathogenesis (2021)

3. Chen et al., ITCH-mediated mitophagy in Parkinson’s disease (2023)

4. Sanchez et al., HECT E3 ligases in protein aggregation disorders (2020)

5. Wang et al., ITCH regulates synaptic plasticity (2021)

Cross-References

• ITCH Gene

• Ubiquitin-Proteasome System

• Alzheimer’s Disease

• Parkinson’s Disease

• Protein Aggregation

• Autophagy

Pathway & Interaction Diagram

Interactive diagram showing ITCH’s key relationships in the SciDEX knowledge graph (6 connections shown).

flowchart TD
    ITCH(["ITCH"])
    Lysophagy("Lysophagy")
    SPG20(["SPG20"])
    UBIQUITIN(["UBIQUITIN"])
    LYSOSOME(["LYSOSOME"])

    ITCH -->|"associated with"| Lysophagy
    SPG20 -->|"associated with"| ITCH
    SPG20 -->|"activates"| ITCH
    ITCH -->|"catalyzes"| UBIQUITIN
    ITCH -->|"activates"| LYSOSOME
    UBIQUITIN -->|"activates"| ITCH

    style ITCH fill:#1a237e,stroke:#4fc3f7,stroke-width:3px,color:#fff

See Also

• Ubiquitin-Proteasome System

• Alzheimer’s Disease

• Parkinson’s Disease

• Protein Aggregation

• Autophagy

External Links

• UniProt: itch

• PubMed: itch